7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent

Cell Biol Toxicol. 2009 Apr;25(2):127-39. doi: 10.1007/s10565-008-9063-0. Epub 2008 Mar 4.

Abstract

Oxysterols found in oxidized low-density lipoproteins are probably involved in the appearance of atheroma; some are cytotoxic and some able to induce cytokine secretion. An oxysterol-induced interleukin-8 (IL-8) secretion in human monocytes/macrophages has been previously noticed, but the mechanisms remained unclear. In this paper, we investigated the signaling pathways leading to the induction of IL-8 secretion in monocytic THP-1 cells treated with 7beta-hydroxycholesterol, a cytototoxic oxysterol, or with 25-hydroxycholesterol, an oxysterol non-cytotoxic toward this cell line. The oxysterol-induced IL-8 secretion appears to be a calcium-dependent phenomenon as shown by the use of calcium channel blockers, which strongly decreased IL-8 secretion and IL-8 messenger RNA (mRNA) levels. Fluo-3 staining used in flow cytometry and video microscopy revealed an oxysterol-induced Ca(2+) influx, varying according to the oxysterol studied, leading to the activation of the MEK/ERK1/2 pathway as demonstrated by Western blot analysis. ERK activation led to an increase of c-fos mRNA and/or an activation of c-fos. Luciferase reporter gene assay using constructs of the human IL-8 gene promoter and Transam assay revealed the involvement of the AP-1 transcription factor in oxysterol-dependent IL-8 secretion. These results demonstrate that oxysterol-induced IL-8 secretion is a calcium-dependent phenomenon involving the MEK/ERK1/2 pathway leading to the activation of IL-8 gene via AP-1 (c-fos).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Cell Line
  • Gene Expression / drug effects
  • Gene Expression / immunology
  • Humans
  • Hydroxycholesterols / metabolism
  • Hydroxycholesterols / pharmacology*
  • Interleukin-8 / genetics
  • Interleukin-8 / metabolism*
  • Lipoproteins, LDL / metabolism
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / immunology*
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Monocytes / cytology
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • Nifedipine / pharmacology
  • Proto-Oncogene Proteins c-fos / metabolism
  • RNA, Messenger / metabolism
  • Transcription Factor AP-1 / metabolism
  • Verapamil / pharmacology

Substances

  • Calcium Channel Blockers
  • Hydroxycholesterols
  • Interleukin-8
  • Lipoproteins, LDL
  • Proto-Oncogene Proteins c-fos
  • RNA, Messenger
  • Transcription Factor AP-1
  • oxidized low density lipoprotein
  • cholest-5-en-3 beta,7 alpha-diol
  • 25-hydroxycholesterol
  • Verapamil
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Nifedipine
  • Calcium